The Net Margin of China Regenerative Medicine International Ltd (8158.HK) is 19.59%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | 19.59% |
| 2023-12-31 | -154.99% |
| 2022-12-31 | 1.97% |
| 2021-12-31 | 4.72% |
| 2020-12-31 | -221.94% |
| 2019-12-31 | -2039.79% |
| 2018-12-31 | -1636.01% |
| 2017-12-31 | -31.47% |
| 2017-04-30 | -51.68% |
| 2016-04-30 | -687.91% |